Latest Respiratory physiology Stories
WARRINGTON, Pa., May 8, 2014 /PRNewswire/ -- Discovery Laboratories, Inc.
WARRINGTON, Pa., May 7, 2014 /PRNewswire/ -- Discovery Laboratories, Inc.
WARRINGTON, Pa., May 6, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical
- First results of the pivotal Phase 3 INPULSIS(TM) trials investigating the efficacy and safety of nintedanib, an investigational compound, in the treatment of idiopathic pulmonary fibrosis (IPF)
A new prediction tool can help doctors better identify patients who are at highest risk for respiratory failure after surgery and therefore prevent the often deadly condition.
Young adults who run or participate in other cardio fitness activities may preserve their memory and thinking skills in middle age.
Conference Call Today, March 13, 2014 at 10:00 a.m. ET WARRINGTON, Pa., March 13, 2014 /PRNewswire/ -- Discovery Laboratories, Inc.
WARRINGTON, Pa., March 11, 2014 /PRNewswire/ -- Discovery Laboratories, Inc.
This unique program will bring together key stakeholders who have a shared goal of improving the treatment and management of patient’s with Chronic Obstructive Pulmonary Disease (COPD).
Rapid rehabilitation is a must after a heart attack or other cardiovascular event.
- A transitional zone between two communities containing the characteristic species of each.